Parvez S: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
{{Person}} | {{Person | ||
|lastname=Parvez | |||
|firstname=Suhel | |||
|institution=Klinik für Neurologie, Univ. Magdeburg | |||
|address=Leipziger Str. 44 | |||
|city=Magdeburg | |||
|country=Germany | |||
}} | |||
{{Labelingperson}} | |||
==Participated at== | |||
::::* [[IOC27|IOC27 Schroecken AT]] | |||
Latest revision as of 14:41, 12 February 2018
| Name | Parvez Suhel, |
|---|---|
| Institution | Klinik für Neurologie, Univ. Magdeburg |
| Address | Leipziger Str. 44, |
| City | Magdeburg |
| State/Province | |
| Country | Germany |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | DE Magdeburg Debska-Vielhaber G |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Parvez 2010 Biochim Biophys Acta | 2010 | Parvez S, Winkler-Stuck K, Hertel S, Schoenfeld P, Siemen D (2010) The dopamine-D2-receptor agonist ropinirole dose-dependently blocks the Ca(2+)-triggered permeability transition of mitochondria. Biochim Biophys Acta 1797:1245-50. |
Abstracts
